P
Purple Biotech Ltd
NASDAQ:PPBT
Purple Biotech Ltd
NASDAQ:PPBT
Price:
4.1399
USD
0.73%
Market Closed
Market Cap:
$140.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Purple Biotech Ltd
NASDAQ:PPBT
|
IL |
|
P
|
PB Bankshares Inc
NASDAQ:PBBK
|
US |
|
Sartorius AG
OTC:SARTF
|
DE |
|
I
|
Ianthus Capital Holdings Inc
CNSX:IAN
|
CA |
|
Field Trip Health Ltd
TSX:FTRP
|
CA |
|
C
|
Clean Teq Water Ltd
ASX:CNQ
|
AU |
|
Sindoh Co Ltd
KRX:029530
|
KR |
|
Atco Ltd
TSX:ACO.Y
|
CA |
|
A
|
Aju IB Investment Co Ltd
KOSDAQ:027360
|
KR |
|
J
|
JCK Hospitality PCL
SET:JCKH
|
TH |
|
T
|
Telsys Ltd
TASE:TLSY
|
IL |
Multiples-Based Value
The Multiples-Based Value of one PPBT stock under the Base Case scenario is hidden USD. Compared to the current market price of 4.1399 USD, Purple Biotech Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PPBT Multiples-Based Value
LOCKED
Multiples Across Competitors
PPBT Competitors Multiples
Purple Biotech Ltd Competitors
Purple Biotech Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IL |
P
|
Purple Biotech Ltd
NASDAQ:PPBT
|
17.8m USD | 0 | -1.8 | 1 | 0.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
875.9B USD | 13.4 | 42.4 | 28.6 | 30.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
580.2B USD | 6.2 | 21.6 | 15 | 18.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.2 | 30.1 | 16.6 | 23.5 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.6 | 16.4 | 10.2 | 12.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.1 | 20.7 | 12.8 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
158.2B USD | 2.5 | 20.4 | 7.8 | 10.4 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.4B USD | 2.5 | 16.9 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
